This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Mar 19;360(12):1254; author reply 1255.

doi: 10.1056/NEJMc090023.

Antimalarial therapies in children from Papua New Guinea

Ric N Price, Grant Dorsey, Francois Nosten

PMID: 19297580
DOI: 10.1056/NEJMc090023

Free article

Comment

Antimalarial therapies in children from Papua New Guinea

Ric N Price et al. N Engl J Med. 2009.

Free article

. 2009 Mar 19;360(12):1254; author reply 1255.

doi: 10.1056/NEJMc090023.

Authors

Ric N Price, Grant Dorsey, Francois Nosten

PMID: 19297580
DOI: 10.1056/NEJMc090023

No abstract available

PubMed Disclaimer

Comment on

A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM. Karunajeewa HA, et al. N Engl J Med. 2008 Dec 11;359(24):2545-57. doi: 10.1056/NEJMoa0804915. Epub 2008 Dec 8. N Engl J Med. 2008. PMID: 19064624 Clinical Trial.

Similar articles

Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM). West African Network for Clinical Trials of Antimalarial Drugs (WANECAM). Lancet. 2018 Apr 7;391(10128):1378-1390. doi: 10.1016/S0140-6736(18)30291-5. Epub 2018 Mar 29. Lancet. 2018. PMID: 29606364 Free PMC article. Clinical Trial.
A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM. Karunajeewa HA, et al. N Engl J Med. 2008 Dec 11;359(24):2545-57. doi: 10.1056/NEJMoa0804915. Epub 2008 Dec 8. N Engl J Med. 2008. PMID: 19064624 Clinical Trial.
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
Tavul L, Hetzel MW, Teliki A, Walsh D, Kiniboro B, Rare L, Pulford J, Siba PM, Karl S, Makita L, Robinson L, Kattenberg JH, Laman M, Oswyn G, Mueller I. Tavul L, et al. Malar J. 2018 Oct 5;17(1):350. doi: 10.1186/s12936-018-2494-z. Malar J. 2018. PMID: 30290825 Free PMC article. Clinical Trial.
Artemether-lumefantrine: an option for malaria.
Stover KR, King ST, Robinson J. Stover KR, et al. Ann Pharmacother. 2012 Apr;46(4):567-77. doi: 10.1345/aph.1Q539. Epub 2012 Apr 10. Ann Pharmacother. 2012. PMID: 22496476 Review.
Coartemether (artemether and lumefantrine): an oral antimalarial drug.
Wernsdorfer WH. Wernsdorfer WH. Expert Rev Anti Infect Ther. 2004 Apr;2(2):181-96. doi: 10.1586/14787210.2.2.181. Expert Rev Anti Infect Ther. 2004. PMID: 15482185 Review.

See all similar articles

Cited by

Efficacy and Safety of Artemisinin-Piperaquine for the Treatment of Uncomplicated Malaria: A Systematic Review.
Wang Q, Zou Y, Pan Z, Zhang H, Deng C, Yuan Y, Guo J, Tang Y, Julie N, Wu W, Li G, Li M, Tan R, Huang X, Guo W, Li C, Xu Q, Song J. Wang Q, et al. Front Pharmacol. 2020 Sep 11;11:562363. doi: 10.3389/fphar.2020.562363. eCollection 2020. Front Pharmacol. 2020. PMID: 33013398 Free PMC article.
Aspartate aminotransferase-to-platelet ratio index (APRI): A potential marker for diagnosis in patients at risk of severe malaria caused by Plasmodium vivax.
Guedes KS, Sanchez BAM, Gomes LT, Fontes CJF. Guedes KS, et al. PLoS One. 2019 Nov 25;14(11):e0224877. doi: 10.1371/journal.pone.0224877. eCollection 2019. PLoS One. 2019. PMID: 31765438 Free PMC article.
Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria.
Creek D, Bigira V, Arinaitwe E, Wanzira H, Kakuru A, Tappero J, Kamya MR, Dorsey G, Sandison TG. Creek D, et al. Am J Trop Med Hyg. 2010 Oct;83(4):873-5. doi: 10.4269/ajtmh.2010.10-0158. Am J Trop Med Hyg. 2010. PMID: 20889882 Free PMC article. Clinical Trial.
A molecular survey of acute febrile illnesses reveals Plasmodium vivax infections in Kedougou, southeastern Senegal.
Niang M, Thiam LG, Sow A, Loucoubar C, Bob NS, Diop F, Diouf B, Niass O, Mansourou A, Varela ML, Perraut R, Sall AA, Toure-Balde A. Niang M, et al. Malar J. 2015 Jul 19;14:281. doi: 10.1186/s12936-015-0808-y. Malar J. 2015. PMID: 26186936 Free PMC article.
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Menéndez C, Nambozi M, Valéa I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D'Alessandro U. Bassat Q, et al. PLoS One. 2009 Nov 17;4(11):e7871. doi: 10.1371/journal.pone.0007871. PLoS One. 2009. PMID: 19936217 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information